Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
Background "Phenotyping asthma with airflow obstruction in middle-aged and older adults"
Asthma with fixed airflow obstruction (AFO) is associated with higher exacerbation rates and mortality compared to non-obstructed asthma, yet its prevalence and clinical profile remain uncertain.
Objetives
We aimed to determine the prevalence, characteristics, and comorbidities of asthma with airflow obstruction in adults ≥50 years.
Methods
Participants with spirometry data from 9 CADSET cohorts (n=69,789) were cross-sectionally analyzed. In 2 asthma- and 4 COPD cohorts, AFO was defined as ever diagnosed asthma with post-BD FEV1/FVC<0.7. In 3 population cohorts, AFO was defined as ever asthma with pre-BD FEV1/FVC<0.7. The prevalence and co-morbidities of AFO were meta-analyzed and characteristics were compared to asthma without airflow obstruction (asthma-only) and COPD without asthma history (COPD-only).
Results
The prevalence of AFO was 2.2% (95%CI: 1.8-2.6%) in the general population, 21.0% (18.5-23.8%) in asthma cohorts and 9.9% (5.0-18.7%) in COPD cohorts. AFO patients reported significantly more dyspnea than asthma- and COPD-only. Compared to asthma-only, AFO were older, more often male, current smokers, had lower BMI, and had higher white blood cell counts, yet showed no significant difference in co-morbidities. Compared to COPD-only, AFO were younger, more often female, never smokers, had higher BMI and had more often depression (24.5 vs 11.5%, p=0.01), osteoporosis (21.8 vs 13.4%, p<0.01), and gastro-esophageal reflux disease (GERD; 36.6 vs 24.7%, p<0.01).
Conclusion
AFO is a prevalent respiratory phenotype associated with more dyspnea than asthma- and COPD-only. AFO patients had more depression, osteoporosis, and GERD compared to COPD-only.
Authors
Xander Bertels, Ahmed Edris, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, Claus Vogelmeier, Núria Olvera, Nazanin Zounemat-Kermani, Alvar Agusti, Gavin Donaldson, Jadwiga Wedzicha, Guy Brusselle, Helena Backman, Eva Rönmark, Anne Lindberg, Judith Vonk, Kian Fan Chung, Ian Adcock, Maarten Van Den Berge, Lies Lahousse
Read more
Noticias relacionadas
Phenotypic differences of persistent airflow obstruction in young vs old subjects in the general population
In the general population Persistent Airflow Obstruction (PAO) was largely mild but there are significant phenotypic differences between young and old individuals with PAO
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
The prevalence and diagnostic utility of bronchodilator responsiveness (BDR) in a real-life setting is unclear. Objective: To explore this uncertainty
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits-GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
We explore this concept and look at atopic dermatitis, chronic rhinosinusitis with nasal polyps, etc., as treatable traits of asthma and how these can be managed.
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease
Insight into the impact of doxycycline in therapeutic trials for COPD, emphasizing the need for careful microbiological monitoring in future interventional trials in patients with COPD
Phenotypic differences of persistent airflow obstruction in young vs old subjects in the general population
In the general population Persistent Airflow Obstruction (PAO) was largely mild but there are significant phenotypic differences between young and old individuals with PAO
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
Artículos
Asthma
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 768973·James Fingleton, Rob Mclachlan, Jenny Sparks, Richard Beasley, Alvar Agusti, Peter G Gibson, Ian Pavord, Jo Hardy, Mark Weatherall, Allie Eathorne, Vanessa Mcdonal -Treatable trait guided asthma management: biomarker changes and responder analysis
- 768973·Xander Bertels et Al.- Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET Clinical Research Collaboration
- 769799·Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
- 779273·Teresa M Kole et Al. Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
Estudios
- 759689·Kilian Vellvé et Alt.- Pulmonary vascular reactivity in growth restricted fetuses using computational modelling and machine learning analysis of fetal Doppler waveforms.
- 769273· Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- 769685·Nuria Olvera et Al.- Lung Tissue Multi-Layer Network Analysis Uncovers the Molecular Heterogeneity of COPD
- 769799·Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
- 778991·Mona Bafadhel, Rosa Faner, Camille Taillé, Richard E.K. Russell, Tobias Welte, Peter J. Barnes and Alvar Agustí. Inhaled corticosteroids for the treatment of COVID-19
Imagen obtenida en Canva Pro.
